Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
- PMID: 27768063
- PMCID: PMC5092084
- DOI: 10.3791/52317
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Abstract
Biosafety level 4 (BSL-4) suit laboratories are specifically designed to study high-consequence pathogens for which neither infection prophylaxes nor treatment options exist. The hallmarks of these laboratories are: custom-designed airtight doors, dedicated supply and exhaust airflow systems, a negative-pressure environment, and mandatory use of positive-pressure ("space") suits. The risk for laboratory specialists working with highly pathogenic agents is minimized through rigorous training and adherence to stringent safety protocols and standard operating procedures. Researchers perform the majority of their work in BSL-2 laboratories and switch to BSL-4 suit laboratories when work with a high-consequence pathogen is required. Collaborators and scientists considering BSL-4 projects should be aware of the challenges associated with BSL-4 research both in terms of experimental technical limitations in BSL-4 laboratory space and the increased duration of such experiments. Tasks such as entering and exiting the BSL-4 suit laboratories are considerably more complex and time-consuming compared to BSL-2 and BSL-3 laboratories. The focus of this particular article is to address basic biosafety concerns and describe the entrance and exit procedures for the BSL-4 laboratory at the NIH/NIAID Integrated Research Facility at Fort Detrick. Such procedures include checking external systems that support the BSL-4 laboratory, and inspecting and donning positive-pressure suits, entering the laboratory, moving through air pressure-resistant doors, and connecting to air-supply hoses. We will also discuss moving within and exiting the BSL-4 suit laboratories, including using the chemical shower and removing and storing positive-pressure suits.
Similar articles
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology.J Vis Exp. 2016 Oct 3;(116):53602. doi: 10.3791/53602. J Vis Exp. 2016. PMID: 27768036 Free PMC article.
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.J Vis Exp. 2016 Oct 3;(116):53600. doi: 10.3791/53600. J Vis Exp. 2016. PMID: 27768081 Free PMC article.
-
Development of a Novel Positive Pressure Protective Suit for a Biosafety Level 4 Laboratory in Japan.Jpn J Infect Dis. 2023 Mar 24;76(2):162-166. doi: 10.7883/yoken.JJID.2022.475. Epub 2022 Dec 28. Jpn J Infect Dis. 2023. PMID: 36575023
-
The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.Viruses. 2012 Dec;4(12):3932-51. doi: 10.3390/v4123932. Viruses. 2012. PMID: 23342380 Free PMC article. Review.
-
Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents.Pathobiology. 2021;88(1):37-45. doi: 10.1159/000513438. Epub 2020 Dec 9. Pathobiology. 2021. PMID: 33296902 Free PMC article. Review.
Cited by
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology.J Vis Exp. 2016 Oct 3;(116):53602. doi: 10.3791/53602. J Vis Exp. 2016. PMID: 27768036 Free PMC article.
-
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.Viruses. 2018 Nov 20;10(11):655. doi: 10.3390/v10110655. Viruses. 2018. PMID: 30463334 Free PMC article.
-
An airlock concept to reduce contamination risks during the human exploration of Mars.NPJ Microgravity. 2023 Oct 7;9(1):81. doi: 10.1038/s41526-023-00329-5. NPJ Microgravity. 2023. PMID: 37805607 Free PMC article.
-
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.J Vis Exp. 2016 Oct 3;(116):53600. doi: 10.3791/53600. J Vis Exp. 2016. PMID: 27768081 Free PMC article.
-
Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.Viruses. 2020 Jul 29;12(8):821. doi: 10.3390/v12080821. Viruses. 2020. PMID: 32751087 Free PMC article.
References
-
- NIAID Category A, B, and C Priority Pathogens. National Institute of Allergy and Infectious Diseases. Bethesda, MD,: National Institute; 2013. of Allergy and Infectious Diseases. http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/pages/cata.....
-
- Chosewood LC, Wilson DE. Biosafety in Microbiological and Biomedical Laboratories. 5th. Washington, D.C: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health; 2009. http://www.cdc.gov/biosafety/publications/bmbl5.
-
- Walker J, Stern L. A Guide to the Biosolids Risk Assessments for the EPA Part 503 rule. Washington D.C: US Environmental Protection Agency, Office of Wastewater Management; 1995. http://water.epa.gov/scitech/wastetech/biosolids/503rule_index.cfm.
-
- Salkin IF, Krisiunas E, Turnberg WL. Medical and infectious waste management. Appl. Biosaf. 2000;5(2):54–69.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources